DVA DaVita Inc. Common Stock
حول DaVita Inc. Common Stock نظرة عامة على الشركة من ويكيبيديا
DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
اقرأ المزيد
DaVita Inc. (a shortened contraction of "dare vita, meaning "to give life" in the Italian language), incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients (36% of the total of 557,000 patients in the U.S.), and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the Fortune 500.
History
The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare).
In August 1994, 70% of the company was acquired by DLJ Merchant Banking Partners in a leveraged buyout for $75.5 million, including a $10.5 million investment by DLJ. The company then changed its name to Total Renal Care Holdings, Inc. In October 1995, the company became a public company via an initial public offering, raising $107 million. By December 1996, DLJ had made a 386% return on its $10.5 million investment.
Acquisitions and divestments
On February 27, 1998, the company acquired Renal Treatment Centers for $1.3 billion in stock. The integration went poorly and in July 1999, the CEO and CFO resigned. After tripling in value between 1995 and 1998, by July 1999, the stock price was down 71% year-to-date. In October 1999, Kent J. Thiry, then 43 years old, was named CEO.
In 2000, the company sold its non-U.S. operations. In October 2000, the company was renamed DaVita Inc. In October 2005, the company acquired Gambro Healthcare. In 2012, DaVita acquired Healthcare Partners for $4.42 billion, which was renamed DaVita Medical Group. In June 2019, the division was sold to UnitedHealth Group for $4.3 billion. In 2014, DaVita acquired Colorado Springs Health Partners, with 600 employees and 110,000 patients. In March 2016, it acquired the Everett Clinic Medical Group, a 20-site physicians practice with 315,000 patients in the Seattle area, for $385 million. In May 2017, it acquired WellHealth Quality Care.
Legal issues
In October 2014, the company agreed to pay $350 million to settle claims that it provided illegal kickbacks to doctors. In June 2015, the company agreed to pay $450 million to settle allegations that it unnecessarily disposed of drugs and then billed the U.S. federal government for this waste. In June 2018, a jury awarded the families of 3 of the company's patients $383 million in wrongful death claims after the patients died from cardiac arrest after undergoing treatment at DaVita centers. In October 2018, it agreed to pay $270 million to settle allegations that it violated the False Claims Act by providing inaccurate information that caused Medicare Advantage Plans to receive inflated payments. James Swoben, a whistleblower, received $10 million.
In July 2021, a federal grand jury indicted DaVita and former CEO Kent Thiry on charges of labor market collusion alleging participation in conspiracies with Surgical Care Affiliates to suppress competition for the services of certain senior-level employees. The company and Thiry were acquitted by a jury in April 2022. In October 2021, the Federal Trade Commission imposed limits on the company engaging in more mergers in Utah because of its history of buying up competitors.
In 2024, the Federal Trade Commission began investigating Davita along with Fresenius Medical Care under allegations they use illegal tactics to push smaller companies out of the market. In May 2025, the benefits fund of the United Food and Commercial Workers Local 1776 filed a proposed class-action lawsuit against DaVita and Fresenius Medical Care, a rival dialysis provider, alleging that the two companies illegally conspired to inflate treatment costs.
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
DVA لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
DVA مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
التوزيعات العائد، نسبة التوزيع، تاريخ توزيع الأرباح، معدل النمو السنوي المركب لمدة 5 سنوات
DVA توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
- شراء قوي 1 7,7%
- شراء 5 38,5%
- احتفاظ 6 46,2%
- بيع 1 7,7%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
7 محللين · 2026-08-16سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $4.02 | $3.92 | 0.10% |
| 31 مارس، 2026 | $2.87 | $2.34 | 0.53% |
| 31 ديسمبر، 2025 | $3.40 | $3.19 | 0.21% |
| 30 سبتمبر، 2025 | $2.04 | $3.25 | -1.2% |
| 30 يونيو، 2025 | $2.95 | $2.83 | 0.12% |
| 31 مارس، 2025 | $2.00 | $1.97 | 0.03% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | — |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 13
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| SG&A Expense | $1.67B | $1.54B | $1.47B | $1.36B | $1.20B | $1.25B | $1.10B | $1.14B | $1.06B | $1.07B | |
| Operating Expenses | $11.60B | $10.73B | $10.54B | $10.27B | $9.82B | $9.86B | $9.75B | $9.88B | $9.06B | $8.68B | |
| Operating Income | $2.04B | $2.09B | $1.60B | $1.34B | $1.80B | $1.69B | $1.64B | $1.53B | $1.81B | $2.03B | |
| Other Non-op | $-103M | $-70M | $-19M | $-16M | $6M | $17M | $29M | $10M | $18M | $8M | |
| Pretax Income | $1.35B | $1.53B | $1.18B | $966M | $1.52B | $1.32B | $1.20B | $1.05B | $1.40B | $1.62B | |
| Income Tax | $293M | $280M | $220M | $198M | $307M | $314M | $280M | $258M | $324M | $432M | |
| Net Income | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| EPS (Basic) | $10.06 | $11.02 | $7.62 | $6.03 | $9.30 | $6.46 | $5.29 | $0.93 | $3.52 | $4.36 | |
| EPS (Diluted) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 | |
| Shares (Basic) | 74,227,000 | 84,991,000 | 90,790,000 | 92,992,000 | 105,230,000 | 119,797,000 | 153,181,000 | 170,786,000 | 188,625,559 | 201,641,173 | |
| Shares (Diluted) | 75,885,000 | 87,274,000 | 93,182,000 | 95,834,000 | 109,948,000 | 122,623,000 | 153,812,000 | 172,365,000 | 191,348,533 | 204,904,656 | |
| EBITDA | $2.75B | $2.81B | $2.34B | $2.06B | $2.47B | $2.31B | $2.24B | $2.10B | $2.36B | $2.44B |
الميزانية العمومية 27
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $795M | $380M | $244M | $462M | $325M | $1.10B | $323M | $508M | $675M | |
| Short-term Investments | $24M | $51M | $12M | $78M | $22M | $20M | $12M | $3M | $33M | $307M | |
| Receivables | $2.41B | $2.15B | $1.99B | $2.13B | $1.96B | $1.82B | $1.80B | $1.86B | $1.71B | $1.50B | |
| Inventory | $161M | $135M | $143M | $109M | $107M | $112M | $98M | $107M | $182M | $160M | |
| Prepaid Expense | $156M | $123M | $103M | $79M | $73M | $76M | $67M | $112M | $112M | $100M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $112M | $100M | |
| Current Assets | $4.06B | $3.75B | $3.14B | $3.16B | $3.17B | $3.15B | $3.69B | $8.42B | $8.77B | $3.99B | |
| PP&E (Net) | $2.81B | $2.94B | $3.07B | $3.26B | $3.48B | $3.52B | $3.47B | $3.39B | $3.15B | $2.86B | |
| PP&E (Gross) | $9.42B | $9.20B | $8.83B | $8.52B | $8.24B | $8.00B | $7.44B | $6.92B | $6.25B | $5.56B | |
| Accum. Depreciation | $6.60B | $6.26B | $5.76B | $5.27B | $4.76B | $4.48B | $3.97B | $3.52B | $3.10B | $2.70B | |
| Goodwill | $7.55B | $7.38B | $7.11B | $7.08B | $7.05B | $6.92B | $6.79B | $6.84B | $6.61B | $6.02B | |
| Intangibles | $222M | $197M | $203M | $183M | $178M | $167M | $136M | $119M | $114M | $74M | |
| Other Non-current Assets | $247M | $262M | $271M | $316M | $137M | $80M | $116M | $72M | $47M | $34M | |
| Total Assets | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Accounts Payable | $696M | $547M | $515M | $480M | $402M | $434M | $404M | $463M | $509M | $457M | |
| Current Liabilities | $3.14B | $2.97B | $2.64B | $2.62B | $2.40B | $2.48B | $2.37B | $4.89B | $3.07B | $2.71B | |
| Capital Leases | $2.18B | $2.21B | $2.33B | $2.50B | $2.67B | $2.74B | $2.72B | $0 | · | · | |
| Deferred Tax | $757M | $665M | $726M | $783M | $831M | $810M | $578M | $563M | $486M | $531M | |
| Other Non-current Liabilities | $84M | $170M | $183M | $105M | $119M | $150M | $161M | $451M | $365M | $317M | |
| Total Liabilities | $16.32B | $15.19B | $14.15B | $14.70B | $14.75B | $14.09B | $13.81B | $14.08B | $13.08B | $12.93B | |
| Common Stock | $69.0K | $90.0K | $89.0K | $90.0K | $97.0K | $110.0K | $126.0K | $166.0K | $182.0K | $195.0K | |
| Retained Earnings | $-328M | $1.53B | $598M | $174M | $354M | $853M | $1.43B | $2.74B | $3.63B | $3.71B | |
| Treasury Stock | $200M | $1.39B | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| AOCI | $-123M | $-311M | $-52M | $-69M | $-139M | $-66M | $-47M | $-35M | $13M | $-90M | |
| Stockholders' Equity | $-651M | $121M | $1.06B | $712M | $756M | $1.38B | $2.13B | $3.70B | $4.69B | $4.65B | |
| Liabilities + Equity | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Shares Outstanding | 68,549,000 | 90,369,000 | 88,824,000 | 90,411,000 | 97,289,000 | 109,933,000 | 125,843,000 | 166,387,000 | 182,462,000 | 194,554,000 |
التدفق النقدي 17
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708M | $716M | $736M | $721M | $668M | $617M | $601M | $575M | $544M | $495M | |
| Stock-based Comp | $140M | $103M | $112M | $95M | $102M | $91M | $68M | $73M | $35M | $38M | |
| Deferred Tax | $87M | $-58M | $-39M | $-76M | $60M | $241M | $42M | $274M | $-395M | $52M | |
| Amort. of Intangibles | $7M | $7M | $9M | $11M | $13M | $14M | $14M | $16M | $16M | $15M | |
| Other Non-cash | $205M | $324M | $558M | $263M | $122M | $256M | $551M | $691M | $1.06B | $447M | |
| Operating Cash Flow | $1.89B | $2.02B | $2.06B | $1.56B | $1.93B | $1.98B | $2.07B | $1.77B | $1.91B | $1.97B | |
| CapEx | $576M | $555M | $568M | $603M | $641M | $675M | $767M | $987M | $905M | $829M | |
| Investing Cash Flow | $-655M | $-771M | $-772M | $-630M | $-785M | $-825M | $3.00B | $-1.01B | $-1.36B | $-1.20B | |
| Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Net Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Stock Repurchased | $1.31B | $1.39B | $272M | $802M | $1.54B | $1.46B | $2.38B | $1.16B | $803M | $1.10B | |
| Net Stock Activity | $-1.31B | $-1.39B | $-272M | $-802M | $-1.54B | $-1.46B | $-2.38B | $-1.16B | $-803M | $-1.10B | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Financing Cash Flow | $-1.37B | $-817M | $-1.17B | $-1.12B | $-1.08B | $-1.85B | $-4.70B | $-625M | $-766M | $-1.35B | |
| Net Change in Cash | $-122M | $415M | $126M | $-216M | $53M | $-707M | $369M | $137M | $-218M | $-577M | |
| Taxes Paid | $177M | $388M | $268M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.31B | $1.47B | $1.49B | $961M | $1.29B | $1.30B | $1.31B | $785M | $1.00B | $1.13B |
الربحية 7
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | · | · | |
| Net Margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | · | · | |
| Pretax Margin | 9.9% | 11.9% | 9.7% | 8.3% | 13.1% | 11.4% | 10.5% | 9.2% | · | · | |
| EBITDA Margin | 20.2% | 21.9% | 19.3% | 17.8% | 21.2% | 20.0% | 19.7% | 18.4% | · | · | |
| ROA | 4.3% | 5.5% | 4.1% | 3.3% | 5.7% | 4.5% | 4.5% | 0.84% | 3.5% | 4.7% | |
| ROE | -281.8% | 159.1% | 78.2% | 76.4% | 91.5% | 44.0% | 27.8% | 3.8% | 14.2% | 18.5% | |
| ROIC | -245.6% | 1410.5% | 123.4% | 149.4% | 189.8% | 93.3% | 59.0% | 31.1% | 29.7% | 28.3% |
السيولة والملاءة 2
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 | 1.3 | 1.6 | 1.7 | 2.9 | 1.5 | |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9 | 1.2 | 0.4 | 0.7 | 1.2 |
الكفاءة 2
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | · | · | |
| Receivables Turnover | 6.0 | 6.2 | 5.9 | 5.7 | 6.1 | 6.4 | 6.2 | 6.4 | · | · |
معدلات النمو 9
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.5% | 5.6% | 4.6% | -0.08% | 0.59% | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.5% | 3.3% | 1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.3% | 44.6% | 26.8% | -34.3% | 41.0% | · | · | · | · | · | |
| EPS CAGR 3Y | 18.9% | 6.4% | 5.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -20.2% | 35.4% | 23.4% | -42.7% | 26.5% | · | · | · | · | · | |
| Net Income CAGR 3Y | 10.0% | -1.5% | -3.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.70% | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 12
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| Net Income TTM | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| Market Cap | $7.79B | $12.04B | $9.31B | $6.75B | $11.07B | $12.91B | $9.44B | $8.56B | $13.18B | $12.49B | |
| P/E | 11.5 | 13.9 | 14.1 | 12.8 | 12.8 | 18.6 | 14.2 | 55.9 | 20.8 | 15.0 | |
| P/S | 0.6 | 0.9 | 0.8 | 0.6 | 1.0 | 1.1 | 0.8 | 0.8 | 1.2 | 1.2 | |
| P/B | -12.0 | 99.4 | 8.8 | 9.5 | 14.6 | 9.3 | 4.4 | 2.3 | 2.8 | 2.7 | |
| P / Cash Flow | 4.1 | 6.0 | 4.5 | 4.3 | 5.7 | 6.5 | 4.6 | 4.8 | 6.9 | 6.4 | |
| P / FCF | 5.9 | 8.2 | 6.2 | 7.0 | 8.6 | 9.9 | 7.2 | 10.9 | 13.2 | 11.0 | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | |
| Earnings Yield | 8.7% | 7.2% | 7.1% | 7.8% | 7.8% | 5.4% | 7.0% | 1.8% | 4.8% | 6.7% | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · |
قائمة الدخل 13
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | $3.22B | $3.29B | $3.26B | $3.19B | $3.07B | $3.15B | $3.12B | $3.00B | $2.87B | $2.92B | $2.95B | |
| SG&A Expense | $423M | $422M | $472M | $414M | $413M | $374M | $414M | $394M | $368M | $362M | $401M | $377M | $364M | $332M | $380M | $365M | |
| Operating Expenses | $2.98B | $2.93B | $3.06B | $2.91B | $2.84B | $2.78B | $2.73B | $2.73B | $2.68B | $2.59B | $2.76B | $2.63B | $2.60B | $2.56B | $2.66B | $2.64B | |
| Operating Income | $579M | $482M | $561M | $506M | $538M | $439M | $565M | $535M | $506M | $484M | $390M | $496M | $405M | $312M | $256M | $312M | |
| Other Non-op | $8M | $4M | $-21M | $-41M | $-23M | $-18M | $-13M | $-17M | $-27M | $-13M | $-5M | $-20M | $1M | $4M | $-8M | $-5M | |
| Pretax Income | $435M | $341M | $383M | $309M | $369M | $286M | $414M | $373M | $371M | $372M | $289M | $378M | $295M | $215M | $147M | $207M | |
| Income Tax | $92M | $66M | $77M | $69M | $94M | $54M | $64M | $78M | $72M | $66M | $58M | $69M | $49M | $44M | $34M | $43M | |
| Net Income | $265M | $198M | $234M | $150M | $199M | $163M | $259M | $215M | $223M | $240M | $151M | $247M | $179M | $116M | $68M | $105M | |
| EPS (Basic) | $4.10 | $2.93 | $3.30 | $2.09 | $2.62 | $2.05 | $3.17 | $2.56 | $2.56 | $2.73 | $1.68 | $2.70 | $1.96 | $1.28 | $0.81 | $1.16 | |
| EPS (Diluted) | $4.02 | $2.87 | $3.22 | $2.04 | $2.58 | $2.00 | $3.08 | $2.50 | $2.50 | $2.65 | $1.64 | $2.62 | $1.91 | $1.25 | $0.81 | $1.13 | |
| Shares (Basic) | 64,781,000 | 67,390,000 | -153,159,000 | 72,075,000 | 75,943,000 | 79,368,000 | -173,404,000 | 83,721,000 | 86,899,000 | 87,775,000 | -182,013,000 | 91,322,000 | 90,984,000 | 90,497,000 | -188,967,000 | 91,160,000 | |
| Shares (Diluted) | 66,092,000 | 68,875,000 | -156,521,000 | 73,769,000 | 77,362,000 | 81,275,000 | -178,018,000 | 85,795,000 | 88,950,000 | 90,547,000 | -186,760,000 | 94,041,000 | 93,418,000 | 92,483,000 | -195,704,000 | 93,263,000 | |
| EBITDA | $579M | $660M | · | $506M | $538M | $615M | · | $535M | $506M | $671M | · | $496M | $405M | $490M | · | $312M |
الميزانية العمومية 26
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $669M | $644M | $676M | $706M | $708M | $439M | $795M | $1.07B | $416M | $345M | · | $449M | $327M | $317M | · | $368M | |
| Short-term Investments | $20M | $22M | $24M | $31M | $31M | $73M | $51M | $21M | $21M | $11M | · | $12M | $12M | $50M | · | $74M | |
| Receivables | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | $2.32B | $2.15B | $2.27B | $2.30B | $2.59B | · | $2.02B | $2.01B | $2.06B | · | $2.09B | |
| Inventory | $152M | $142M | $161M | $139M | $146M | $151M | $135M | $129M | $127M | $146M | · | $110M | $110M | $107M | · | $107M | |
| Prepaid Expense | $149M | $160M | $156M | $161M | $110M | $130M | $123M | $97M | $83M | $105M | · | $91M | $90M | $89M | · | $66M | |
| Current Assets | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B | $4.04B | $3.47B | $3.68B | · | $3.14B | $3.00B | $3.04B | · | $3.20B | |
| PP&E (Net) | $2.75B | $2.75B | $2.81B | $2.85B | $2.85B | $2.90B | $2.94B | $2.94B | $2.98B | $3.03B | · | $3.10B | $3.16B | $3.22B | · | $3.24B | |
| PP&E (Gross) | · | · | $9.42B | · | · | · | $9.20B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $6.87B | · | $6.60B | · | · | · | $6.26B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $7.59B | $7.58B | $7.55B | $7.54B | $7.47B | $7.42B | $7.38B | $7.23B | $7.20B | $7.23B | $7.11B | $7.09B | $7.11B | $7.09B | $7.08B | $7.02B | |
| Intangibles | $229M | $229M | $222M | $220M | $212M | $205M | $197M | $198M | $191M | $201M | · | $185M | $192M | $187M | · | $180M | |
| Other Non-current Assets | $299M | $267M | $247M | $204M | $193M | $239M | $262M | $219M | $240M | $262M | · | $302M | $314M | $291M | · | $308M | |
| Total Assets | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Accounts Payable | $716M | $691M | $696M | $656M | $594M | $596M | $547M | $488M | $494M | $490M | · | $435M | $428M | $448M | · | $417M | |
| Current Liabilities | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | $2.91B | $2.97B | $2.94B | $2.99B | $2.58B | · | $2.54B | $2.40B | $2.57B | · | $2.54B | |
| Capital Leases | $2.19B | $2.16B | $2.18B | $2.10B | $2.12B | $2.16B | $2.21B | $2.24B | $2.28B | $2.31B | · | $2.34B | $2.38B | $2.46B | · | $2.56B | |
| Deferred Tax | $826M | $819M | $757M | $742M | $646M | $665M | $665M | $660M | $694M | $720M | · | $754M | $760M | $771M | · | $819M | |
| Other Non-current Liabilities | $99M | $89M | $84M | $172M | $156M | $167M | $170M | $183M | $179M | $180M | · | $185M | $183M | $100M | · | $107M | |
| Total Liabilities | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B | $15.28B | $14.60B | $14.79B | · | $14.10B | $14.33B | $14.31B | · | $14.89B | |
| Common Stock | $69.0K | $69.0K | $69.0K | $91.0K | $91.0K | $91.0K | $90.0K | $90.0K | $90.0K | $90.0K | · | $91.0K | $91.0K | $91.0K | · | $98.0K | |
| Retained Earnings | $81M | $-179M | $-328M | $2.05B | $1.90B | $1.70B | $1.53B | $1.28B | $1.06B | $838M | · | $715M | $469M | $290M | · | $847M | |
| Treasury Stock | $788M | $489M | $200M | $2.90B | $2.49B | $2.04B | $1.39B | $1.02B | $616M | $240M | · | · | · | · | · | $788M | |
| AOCI | $-59M | $-87M | $-123M | $-116M | $-138M | $-227M | $-311M | $-162M | $-195M | $-100M | · | $-69M | $-7M | $-55M | · | $-136M | |
| Stockholders' Equity | $-765M | $-755M | $-651M | $-572M | $-370M | $-267M | $121M | $387M | $633M | $926M | · | $1.20B | $1.02B | $825M | · | $533M | |
| Liabilities + Equity | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Shares Outstanding | 63,955,000 | 69,190,000 | 68,549,000 | 70,977,000 | 74,217,000 | 77,277,000 | 80,536,000 | 82,624,000 | 85,081,000 | 89,822,000 | 88,824,000 | 91,348,000 | 91,271,000 | 90,650,000 | 90,411,000 | 90,104,000 |
التدفق النقدي 14
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $168M | $178M | $180M | $177M | $175M | $176M | $167M | $187M | $176M | $187M | $186M | $188M | $184M | $178M | $183M | $194M | |
| Stock-based Comp | $26M | $28M | $38M | $39M | $33M | $30M | $27M | $27M | $24M | $25M | $30M | $27M | $30M | $25M | $18M | $28M | |
| Deferred Tax | $-1M | $55M | $18M | $79M | $-14M | $4M | $-4M | $-25M | $-25M | $-3M | $-22M | $-2M | $-13M | $-4M | $-40M | $-45M | |
| Other Non-cash | · | $-137M | · | · | · | $-193M | · | · | · | $-583M | · | · | · | $147M | · | · | |
| Operating Cash Flow | $490M | $321M | $541M | $842M | $324M | $180M | $548M | $810M | $799M | $-135M | $485M | $661M | $450M | $463M | $344M | $711M | |
| CapEx | $170M | $102M | $145M | $166M | $121M | $143M | $171M | $139M | $125M | $121M | $159M | $137M | $124M | $148M | $194M | $144M | |
| Investing Cash Flow | $-194M | $-139M | $-163M | $-263M | $-67M | $-162M | $-248M | $-146M | $-162M | $-215M | $-168M | $-140M | $-347M | $-117M | $-213M | $-154M | |
| Debt Issued | $1.51B | $1.26B | $940M | $482M | $3.56B | $633M | $676.0K | $3.35B | $1.99B | $1.29B | $6.0K | $331M | $1.53B | $612M | $687M | $523M | |
| Net Debt Issued | · | $1.26B | · | · | · | $633M | · | · | · | $1.29B | · | · | · | $612M | · | · | |
| Stock Repurchased | $181M | $196M | $274M | $240M | $284M | $510M | $365M | $408M | $362M | $251M | $272M | $0 | $0 | $0 | $0 | $185M | |
| Net Stock Activity | · | $-196M | · | · | · | $-510M | · | · | · | $-251M | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-270M | $-213M | $-415M | $-582M | $4M | $-383M | $-565M | $-8M | $-563M | $319M | $-403M | $-395M | $-97M | $-276M | $-231M | $-445M | |
| Net Change in Cash | $25M | $-31M | $-38M | $-2M | $272M | $-355M | $-279M | $655M | $72M | $-34M | $-80M | $123M | $11M | $72M | $-123M | $106M | |
| Free Cash Flow | · | $219M | · | · | · | $37M | · | · | · | $-256M | · | · | · | $315M | · | · |
الربحية 7
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 14.1% | · | 14.8% | 15.9% | 13.6% | · | 16.4% | 15.9% | 15.8% | · | 15.9% | 13.5% | 10.8% | · | 10.6% | |
| Net Margin | 7.5% | 5.8% | · | 4.4% | 5.9% | 5.1% | · | 6.6% | 7.0% | 7.8% | · | 7.9% | 6.0% | 4.0% | · | 3.6% | |
| Pretax Margin | 12.2% | 10.0% | · | 9.0% | 10.9% | 8.9% | · | 11.4% | 11.7% | 12.1% | · | 12.1% | 9.8% | 7.5% | · | 7.0% | |
| EBITDA Margin | 16.3% | 19.3% | · | 14.8% | 15.9% | 19.1% | · | 16.4% | 15.9% | 21.9% | · | 15.9% | 13.5% | 17.1% | · | 10.6% | |
| ROA | 1.5% | 1.1% | · | 0.86% | 1.1% | 0.94% | · | 1.2% | 1.3% | 1.4% | · | 1.5% | 1.1% | 0.68% | · | 0.61% | |
| ROE | -46.8% | -38.6% | · | -162.4% | 151.4% | 49.5% | · | 27.1% | 27.0% | 27.4% | · | 28.5% | 22.0% | 13.8% | · | 12.5% | |
| ROIC | -59.7% | -51.4% | · | -68.8% | -108.5% | -133.3% | · | 109.5% | 64.6% | 43.0% | · | 33.8% | 33.2% | 30.0% | · | 46.5% |
السيولة والملاءة 2
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.2 | 1.4 | · | 1.2 | 1.2 | 1.2 | · | 1.3 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 0.9 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 |
الكفاءة 2
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.3 | · | 1.5 | 1.5 | 1.4 | · | 1.4 |
التقييم (آخر 12 شهرًا) 9
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.77B | $13.44B | · | $13.29B | $13.05B | $12.74B | · | $12.64B | $12.38B | $12.06B | · | $11.94B | $11.75B | $11.57B | · | $11.63B | |
| Net Income TTM | $813M | $710M | · | $727M | $800M | $840M | · | $924M | $888M | $781M | · | $646M | $624M | $608M | · | $752M | |
| Market Cap | $14.23B | $10.63B | · | $9.43B | $10.57B | $11.82B | · | $13.54B | $11.79B | $12.40B | · | $8.64B | $9.17B | $7.35B | · | $7.46B | |
| P/E | 19.3 | 16.2 | · | 14.6 | 14.9 | 15.9 | · | 16.0 | 14.3 | 16.4 | · | 13.7 | 15.2 | 12.9 | · | 11.2 | |
| P/S | 1.0 | 0.8 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 1.0 | 1.0 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | |
| P/B | -18.6 | -14.1 | · | -16.5 | -28.6 | -44.3 | · | 35.0 | 18.6 | 13.4 | · | 7.2 | 9.0 | 8.9 | · | 14.0 | |
| P / Cash Flow | · | 33.1 | · | · | · | 65.7 | · | · | · | -92.0 | · | · | · | 15.9 | · | · | |
| P / FCF | · | 48.6 | · | · | · | 321.7 | · | · | · | -48.5 | · | · | · | 23.4 | · | · | |
| Earnings Yield | 5.2% | 6.2% | · | 6.9% | 6.7% | 6.3% | · | 6.3% | 7.0% | 6.1% | · | 7.3% | 6.6% | 7.8% | · | 8.9% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| هامش الربح التشغيلي % | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% |
| صافي الدخل | $747M | $936M | $692M | $560M | $978M |
| EPS المخفف | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| النسبة الحالية | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 |
| النسبة السريعة | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $1.31B | $1.47B | $1.49B | $961M | $1.29B |
إشارات التداول إشارات شراء/بيع حديثة مع سعر الدخول ونسبة المخاطرة/المكافأة
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 696 مقدمي إقرار · $7.9B إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 131 (-1 مقابل الربع السابق) | 59 (-5 مقابل الربع السابق) | 184 (+11 مقابل الربع السابق) | 217 (+12 مقابل الربع السابق) | +3.7M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| Berkshire Hathaway Inc | $3331328308 | 14973608 | 42,04% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $467525034 | 2101425 | 5,90% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $306558307 | 1377914 | 3,87% | الأسهم |
| STATE STREET CORP | $294345267 | 1323019 | 3,71% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $235869514 | 1060183 | 2,98% | الأسهم |
| NEUBERGER BERMAN GROUP LLC | $199315922 | 896621 | 2,52% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $197802963 | 889082 | 2,50% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $165824664 | 746907 | 2,09% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $163166832 | 733400 | 2,06% | عقد خيار الشراء |
| Gates Capital Management, Inc. | $153096497 | 688136 | 1,93% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $133302007 | 599164 | 1,68% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $81331791 | 365569 | 1,03% | الأسهم |
| NORGES BANK | $76627007 | 344422 | 0,97% | الأسهم |
| NORDEA INVESTMENT MANAGEMENT AB | $67404554 | 305067 | 0,85% | الأسهم |
| GOLDMAN SACHS GROUP INC | $63752756 | 286555 | 0,80% | الأسهم |
| D. E. Shaw & Co., Inc. | $62040995 | 278861 | 0,78% | الأسهم |
| JANE STREET GROUP, LLC | $53573184 | 240800 | 0,68% | عقد خيار الشراء |
| Holocene Advisors, LP | $52875709 | 237665 | 0,67% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48100176 | 216200 | 0,61% | عقد خيار البيع |
| Quantinno Capital Management LP | $45366106 | 203910 | 0,57% | الأسهم |
| CITADEL ADVISORS LLC | $44465298 | 199862 | 0,56% | الأسهم |
| CITADEL ADVISORS LLC | $44184528 | 198600 | 0,56% | عقد خيار الشراء |
| VANGUARD FIDUCIARY TRUST CO | $40134502 | 180396 | 0,51% | الأسهم |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $37089700 | 241328 | 0,47% | الأسهم |
| Gotham Asset Management, LLC | $36393278 | 163580 | 0,46% | الأسهم |
| JANE STREET GROUP, LLC | $35774784 | 160800 | 0,45% | عقد خيار البيع |
| Doma Perpetual Capital Management LLC | $35522937 | 159668 | 0,45% | الأسهم |
| FIRST TRUST ADVISORS LP | $34161205 | 153548 | 0,43% | الأسهم |
| TODD ASSET MANAGEMENT LLC | $32697663 | 146969 | 0,41% | الأسهم |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $32011312 | 143884 | 0,40% | الأسهم |
| Allianz Asset Management GmbH | $30236367 | 135906 | 0,38% | الأسهم |
| MORGAN STANLEY | $28624054 | 128659 | 0,36% | الأسهم |
| Toroso Investments, LLC | $28283664 | 248954 | 0,36% | الأسهم |
| CANADA PENSION PLAN INVESTMENT BOARD | $26480460 | 119024 | 0,33% | الأسهم |
| BlackRock, Inc. | $26457544 | 118921 | 0,33% | الأسهم |
| VICTORY CAPITAL MANAGEMENT INC | $26377896 | 118563 | 0,33% | الأسهم |
| Amundi | $25967198 | 116717 | 0,33% | الأسهم |
| BARCLAYS PLC | $25933826 | 116567 | 0,33% | الأسهم |
| Davidson Kempner Capital Management LP | $25162043 | 113098 | 0,32% | الأسهم |
| ENVESTNET ASSET MANAGEMENT INC | $23582658 | 105999 | 0,30% | الأسهم |
| VANGUARD GROUP INC | $23117136 | 203478 | 0,29% | الأسهم |
| RHUMBLINE ADVISERS | $23076629 | 103725 | 0,29% | الأسهم |
| Woodline Partners LP | $22872501 | 102807 | 0,29% | الأسهم |
| UBS Group AG | $20846376 | 93700 | 0,26% | عقد خيار البيع |
| MILLENNIUM MANAGEMENT LLC | $20579400 | 92500 | 0,26% | عقد خيار البيع |
| FMR LLC | $20183608 | 90721 | 0,25% | الأسهم |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $19532854 | 87796 | 0,25% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $17151873 | 77094 | 0,22% | الأسهم |
| California Public Employees Retirement System | $15370253 | 69086 | 0,19% | الأسهم |
| Swiss National Bank | $14906160 | 67000 | 0,19% | الأسهم |
| Vanguard Global Advisers, LLC | $14696806 | 66059 | 0,19% | الأسهم |
| WOLVERINE TRADING, LLC | $14482431 | 110900 | 0,18% | عقد خيار البيع |
| National Philanthropic Trust | $14000889 | 62931 | 0,18% | الأسهم |
| PineBridge Investments, L.P. | $13874153 | 104419 | 0,18% | الأسهم |
| TUDOR INVESTMENT CORP ET AL | $13325440 | 59895 | 0,17% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $13022644 | 58534 | 0,16% | الأسهم |
| Candriam S.C.A. | $12727615 | 57263 | 0,16% | الأسهم |
| DANSKE BANK A/S | $12471116 | 56055 | 0,16% | الأسهم |
| CITADEL ADVISORS LLC | $12280896 | 55200 | 0,15% | عقد خيار البيع |
| Susquehanna Portfolio Strategies, LLC | $12219714 | 54925 | 0,15% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $11902680 | 53500 | 0,15% | عقد خيار الشراء |
| STOREBRAND ASSET MANAGEMENT AS | $11500659 | 51693 | 0,15% | الأسهم |
| LPL Financial LLC | $10778934 | 48449 | 0,14% | الأسهم |
| Robeco Institutional Asset Management B.V. | $10083684 | 45324 | 0,13% | الأسهم |
| Callahan Advisors, LLC | $10033403 | 45098 | 0,13% | الأسهم |
| Assenagon Asset Management S.A. | $9963322 | 44783 | 0,13% | الأسهم |
| Verition Fund Management LLC | $9740174 | 43780 | 0,12% | الأسهم |
| Prospera Financial Services Inc | $9482479 | 42623 | 0,12% | الأسهم |
| Te Ahumairangi Investment Management Ltd | $9480318 | 42612 | 0,12% | الأسهم |
| SEI INVESTMENTS CO | $9251830 | 41585 | 0,12% | الأسهم |
| Connor, Clark & Lunn Investment Management Ltd. | $9207557 | 41386 | 0,12% | الأسهم |
| Inlet Private Wealth, LLC | $9004878 | 40475 | 0,11% | الأسهم |
| Mitsubishi UFJ Asset Management Co., Ltd. | $8835126 | 39712 | 0,11% | الأسهم |
| Caisse de depot et placement du Quebec | $8721216 | 39200 | 0,11% | الأسهم |
| Twin Tree Management, LP | $8454240 | 38000 | 0,11% | عقد خيار الشراء |
| Brevan Howard Capital Management LP | $8343000 | 37500 | 0,11% | عقد خيار الشراء |
| CITIGROUP INC | $8298504 | 37300 | 0,10% | عقد خيار البيع |
| NISA INVESTMENT ADVISORS, LLC | $7947431 | 35722 | 0,10% | الأسهم |
| IEQ CAPITAL, LLC | $7900154 | 35510 | 0,10% | الأسهم |
| UBS Group AG | $7386336 | 33200 | 0,09% | عقد خيار الشراء |
| Counterpoint Mutual Funds LLC | $7384111 | 33190 | 0,09% | الأسهم |
| VANGUARD ASSET MANAGEMENT, Ltd | $7170308 | 32229 | 0,09% | الأسهم |
| FIFTH THIRD BANCORP | $7074159 | 31797 | 0,09% | الأسهم |
| Summit Trail Advisors, LLC | $7043272 | 31658 | 0,09% | الأسهم |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $6953397 | 45243 | 0,09% | الأسهم |
| Corient Private Wealth LP | $6916838 | 31117 | 0,09% | الأسهم |
| Tredje AP-fonden | $6780968 | 30479 | 0,09% | الأسهم |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $6656824 | 29921 | 0,08% | الأسهم |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6539132 | 29392 | 0,08% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6407202 | 28799 | 0,08% | الأسهم |
| NATIONAL BANK OF CANADA /FI/ | $6204782 | 27888 | 0,08% | الأسهم |
| Walleye Capital LLC | $6184944 | 27800 | 0,08% | عقد خيار الشراء |
| GHP Investment Advisors, Inc. | $6107487 | 39739 | 0,08% | الأسهم |
| Wakefield Asset Management LLLP | $5893051 | 26488 | 0,07% | الأسهم |
| STATE OF WISCONSIN INVESTMENT BOARD | $5749551 | 25843 | 0,07% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $5566805 | 36221 | 0,07% | الأسهم |
| NEW YORK STATE COMMON RETIREMENT FUND | $5507937 | 24757 | 0,07% | الأسهم |
| CWA Asset Management Group, LLC | $5003575 | 22490 | 0,06% | الأسهم |
| Legal & General Group Plc | $4992452 | 22440 | 0,06% | الأسهم |
| Mitsubishi UFJ Trust & Banking Corp | $4942393 | 22215 | 0,06% | الأسهم |
المطلعون على الشركة 59 من المطلعين · مسؤولون 31 · مديرون 25
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Javier Rodriguez | Chief Executive Officer | 16 يونيو، 2026 S | 840408 | 0 | 2 | $-14532097 |
| Dennis Kogod | Pres, HCP & CEO, DVA Int. | 17 مايو، 2016 S | 18766 | 0 | 0 | $0 |
| Joel Ackerman | CFO and Treasurer | 7 مايو، 2026 S | 132434 | 0 | 1 | $-9887579 |
| Luis Borgen | Chief Financial Officer | 22 مارس، 2012 M | 18517 | 0 | 0 | $0 |
| Richard K Whitney | Chief Financial Officer | 31 مارس، 2010 A | 33604 | 0 | 0 | $0 |
| Mark G Harrison | Chief Financial Officer | 14 مارس، 2007 A | 31250 | 0 | 0 | $0 |
| Gary Beil | Acting Chief Financial Officer | 1 يوليو، 2006 A | 10000 | 0 | 0 | $0 |
| David Paul Maughan | Chief Operating Officer, DKC | 12 مايو، 2026 S | 94105 | 0 | 2 | $-4089696 |
| Michael David Staffieri | Chief Operating Officer, DKC | 16 أغسطس، 2024 S | 209365 | 0 | 0 | $0 |
| Joseph C Mello | COO, HCP | 24 ديسمبر، 2016 A | 4688 | 0 | 0 | $0 |
| Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | 15 يونيو، 2026 S | 109194 | 0 | 2 | $-3210360 |
| James O Hearty | Chief Compliance Officer | 14 مايو، 2026 M | 22389 | 0 | 2 | $-3291616 |
| Christopher Michael Berry | Chief Accounting Officer | 15 مارس، 2026 A | 19640 | 0 | 0 | $0 |
| John D Winstel | Chief Accounting Officer | 15 مارس، 2023 F | 15676 | 0 | 0 | $0 |
| Leanne M Zumwalt | Group VP, Government Affairs | 18 سبتمبر، 2020 M | 24590 | 0 | 0 | $0 |
| Kent J Thiry | Executive Chairman | 1 يونيو، 2020 F | 110462 | 0 | 0 | $0 |
| James K Hilger | Chief Accounting Officer | 2 يونيو، 2019 F | 33125 | 0 | 0 | $0 |
| Jeanine Marie Jiganti | Chief Compliance Officer | 13 يونيو، 2017 M | 3514 | 0 | 0 | $0 |
| Kim M Rivera | Chief Legal Officer | 22 سبتمبر، 2015 M | 7438 | 0 | 0 | $0 |
| Robert J Margolis | Co-Chairman of the Board | 4 يونيو، 2015 S | 2322928 | 0 | 0 | $0 |
| Allen Nissenson | Chief Medical Officer | 13 فبراير، 2014 M | 8990 | 0 | 0 | $0 |
| Garry E Menzel | Senior Vice President, Finance | 9 سبتمبر، 2013 A | — | 0 | 0 | $0 |
| David T Shapiro | Chief Special Counsel | 2 أغسطس، 2013 G | 2315 | 0 | 0 | $0 |
| Thomas O Usilton | Senior Vice President | 29 فبراير، 2012 M | 17491 | 0 | 0 | $0 |
| Georgina Randolph | Senior Vice President | 17 يونيو، 2009 M | 5547 | 0 | 0 | $0 |
| Joseph Schohl | VP, Gen. Counsel & Secretary | 13 فبراير، 2009 M | 2084 | 0 | 0 | $0 |
| Christopher J Riopelle | Chief Compliance Officer | 11 أغسطس، 2008 M | 2500 | 0 | 0 | $0 |
| Mary Kowenhoven | Vice President - Strategy | 5 مارس، 2008 A | — | 0 | 0 | $0 |
| Patricia Jones | Chief People Officer | 16 يوليو، 2007 A | 6250 | 0 | 0 | $0 |
| Charles J Mcallister | Chief Medical Officer | 8 مايو، 2007 M | 999 | 0 | 0 | $0 |
| Thomas L Kelly | Executive Vice President | 4 نوفمبر، 2005 M | 42000 | 0 | 0 | $0 |
| Dennis W Pullin | مدير | 15 أغسطس، 2026 A | 2949 | 0 | 0 | $0 |
| Gregory J. Moore | مدير | 15 أغسطس، 2026 A | 8091 | 0 | 0 | $0 |
| Jason M. Hollar | مدير | 15 أغسطس، 2026 A | 6883 | 0 | 0 | $0 |
| Patricia M Arway | مدير | 15 أغسطس، 2026 A | 27223 | 0 | 0 | $0 |
| Adam H Schechter | مدير | 15 أغسطس، 2026 A | 5970 | 0 | 0 | $0 |
| Wendy Lee Schoppert | مدير | 15 أغسطس، 2026 A | 278 | 0 | 0 | $0 |
| Phyllis R Yale | مدير | 15 أغسطس، 2026 A | 9803 | 0 | 0 | $0 |
| Barbara J Desoer | مدير | 15 أغسطس، 2026 A | 278 | 0 | 0 | $0 |
| Charles Berg | مدير | 15 مايو، 2025 A | 19982 | 0 | 0 | $0 |
| John M Nehra | مدير | 15 مايو، 2024 A | 363 | 0 | 0 | $0 |
| Paul J Diaz | مدير | 15 مايو، 2023 A | 16069 | 0 | 0 | $0 |
| Paula A Price | مدير | 15 مايو، 2022 A | 1395 | 0 | 0 | $0 |
| Shawn M Guertin | مدير | 15 مايو، 2021 A | 1105 | 0 | 0 | $0 |
| Pascal Desroches | مدير | 15 نوفمبر، 2020 A | 8030 | 0 | 0 | $0 |
| William L Roper | مدير | 11 يونيو، 2020 A | 16234 | 0 | 0 | $0 |
| Peter T Grauer | مدير | 11 يونيو، 2020 A | 76204 | 0 | 0 | $0 |
| Carol Anthony Davidson | مدير | 31 ديسمبر، 2017 A | 10764 | 0 | 0 | $0 |
| Willard Woodson Brittain JR | مدير | 11 يونيو، 2012 A | 7195 | 0 | 0 | $0 |
| Richard C Vaughan | مدير | 13 مايو، 2010 A | 6092 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 1 حيازة
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| Warren E. Buffett, Berkshire Hathaway Inc., National Indemnity Company, GEICO Corporation, Government Employees Insurance Company, Berkshire Hathaway Consolidated Pension Plan Master Trust, BNSF Master Retirement Trust, Scott Fetzer Company Collective Investment Trust, R. Ted Weschler ×13 إيداعات | 13 فبراير، 2025 | 45,00% | تعديل | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 130 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| OMAH · Tidal Trust III | 4,50% | 217039 NS | 30 إبريل، 2026 | N-PORT |
| AZTD · Tidal Trust I | 2,74% | 7761 NS | 30 إبريل، 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,19% | 123121 NS | 30 إبريل، 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,40% | 59690 SH | 8 أغسطس، 2026 | يومي |
| AGNG · Global X Funds | 0,92% | 3855 NS | 31 مايو، 2026 | N-PORT |
| IHF · iShares Trust | 0,86% | 58907 SH | 8 أغسطس، 2026 | يومي |
| LSEQ · Harbor ETF Trust | 0,76% | 758 NS | 30 إبريل، 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,56% | 5441 NS | 31 مايو، 2026 | N-PORT |
| ITAN · EA Series Trust | 0,38% | 1735 NS | 29 مايو، 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,38% | 10626 NS | 30 إبريل، 2026 | N-PORT |
| AFLG · First Trust Exchange-Traded Fund VI… | 0,34% | 11220 NS | 31 مايو، 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,31% | 9914 SH | 8 أغسطس، 2026 | يومي |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,30% | 2502 NS | 31 مايو، 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 0,30% | 352 NS | 30 إبريل، 2026 | N-PORT |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | 0,28% | 909000 PA | 8 أغسطس، 2026 | يومي |
| DFVE · DoubleLine ETF Trust | 0,24% | 425 NS | 31 مارس، 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,24% | 22988 SH | 8 أغسطس، 2026 | يومي |
| IQSM · New York Life Investments ETF Trust | 0,23% | 4682 NS | 30 إبريل، 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,18% | 635 NS | 30 إبريل، 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,17% | 934012 SH | 8 أغسطس، 2026 | يومي |
| VBR · VANGUARD INDEX FUNDS | 0,15% | 467367 SH | 8 أغسطس، 2026 | يومي |
| BKMC · BNY Mellon ETF Trust | 0,14% | 5728 NS | 30 إبريل، 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,14% | 1975 NS | 30 إبريل، 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,14% | 124181 NS | 30 إبريل، 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 3564 NS | 30 إبريل، 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,12% | 90512 NS | 31 مايو، 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,11% | 100394 SH | 8 أغسطس، 2026 | يومي |
| ISCG · iShares Trust | 0,11% | 6082 SH | 8 أغسطس، 2026 | يومي |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 14233 NS | 30 إبريل، 2026 | N-PORT |
| ESML · iShares Trust | 0,10% | 15995 SH | 8 أغسطس، 2026 | يومي |
| FHLC · FIDELITY COVINGTON TRUST | 0,10% | 17983 NS | 30 إبريل، 2026 | N-PORT |
| ISCB · iShares Trust | 0,10% | 1555 SH | 8 أغسطس، 2026 | يومي |
| IYH · iShares Trust | 0,09% | 19255 SH | 8 أغسطس، 2026 | يومي |
| RXL · ProShares Trust | 0,09% | 348 NS | 31 مايو، 2026 | N-PORT |
| ISCV · iShares Trust | 0,09% | 3622 SH | 8 أغسطس، 2026 | يومي |
| VB · VANGUARD INDEX FUNDS | 0,09% | 736199 SH | 8 أغسطس، 2026 | يومي |
| SMMD · iShares Trust | 0,08% | 16234 SH | 8 أغسطس، 2026 | يومي |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,08% | 3527 SH | 8 أغسطس، 2026 | يومي |
| CURE · Direxion Shares ETF Trust | 0,07% | 667 NS | 30 إبريل، 2026 | N-PORT |
| IXJ · iShares Trust | 0,07% | 16934 SH | 8 أغسطس، 2026 | يومي |
| SMMV · iShares Trust | 0,07% | 1125 SH | 8 أغسطس، 2026 | يومي |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,07% | 5907 NS | 30 إبريل، 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,07% | 1423 NS | 31 مايو، 2026 | N-PORT |
| DEUS · DBX ETF Trust | 0,07% | 930 NS | 29 مايو، 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,06% | 33893 SH | 8 أغسطس، 2026 | يومي |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 3136 SH | 8 أغسطس، 2026 | يومي |
| WSML · iShares Trust | 0,05% | 1985 SH | 8 أغسطس، 2026 | يومي |
| TILT · FlexShares Trust | 0,05% | 6930 NS | 30 إبريل، 2026 | N-PORT |
| IWS · iShares Trust | 0,05% | 45847 SH | 8 أغسطس، 2026 | يومي |
| DUHP · Dimensional ETF Trust | 0,04% | 32462 NS | 30 إبريل، 2026 | N-PORT |